SQORE
DEAD

Serial Number

97154431

Owner

COMERA LIFE SCIENCES, INC.

Attorney

Aaron D. Hendelman

Filing Date

Dec 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SQORE Trademark

Serial Number: 97154431

SQORE is a trademark filed by COMERA LIFE SCIENCES, INC. on December 3, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently no longer active.

Owner Contact Info

COMERA LIFE SCIENCES, INC. (4 trademarks)

12 GILL STREET, SUITE 4650
WOBURN, MA 01801

Entity Type: 03

ReForm Biologics, Inc. (2 trademarks)

12 Gill Street, Suite 4650
Woburn, MA 01801

Entity Type: 03

Trademark Details

Filing Date

December 3, 2021

Registration Date

Not Registered

Published for Opposition

July 26, 2022

Goods & Services

Manufacturing, processing and treating the therapeutic molecules of others

Biologic medicines for medical diagnosis or treatment of cardiovascular diseases and disorders, gastrointestinal diseases and disorders, cancer, and inflammatory diseases and disorders; Biologic medicines, containing excipients, for medical diagnosis or treatment of cardiovascular diseases and disorders, gastrointestinal diseases and disorders, cancer, and inflammatory diseases and disorders; Biologic medicines consisting of therapeutic biologics and excipients, for medical diagnosis or treatment of cardiovascular diseases and disorders, gastrointestinal diseases and disorders, cancer, and inflammatory diseases and disorders; Biologic medicines consisting of monoclonal antibodies and excipients, for medical diagnosis or treatment of cardiovascular diseases and disorders, gastrointestinal diseases and disorders, cancer, and inflammatory diseases and disorders

Excipients for use in the manufacture of therapeutic compositions

Licensing of intellectual property

Scientific design and development of excipients for use with therapeutic biologics; scientific research and design in the field of therapeutic formulation development; consulting in the fields of therapeutic formulation and excipient development

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 22, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 22, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 21, 2023 EXRA
SOU EXTENSION 2 GRANTED
Sep 19, 2023 EX2G
SOU EXTENSION 2 FILED
Sep 19, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 19, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 16, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 14, 2023 EX1G
SOU EXTENSION 1 FILED
Mar 14, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 14, 2023 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 3, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 3, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 3, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 3, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 3, 2023 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2022 CNSA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 23, 2022 ASGN
EXAMINER'S AMENDMENT ENTERED
Jun 22, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 22, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 22, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 22, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2022 CNRT
ASSIGNED TO EXAMINER
May 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2021 NWOS
NEW APPLICATION ENTERED
Dec 7, 2021 NWAP